News

In the study, Monogram analyzed tissue samples from patients with metastatic breast cancer who were treated with Herceptin, having been selected for such treatment by centralized IHC testing.

The company said that Unite Biomatrix is a novel collagen wound dressing with uncompromised strength to support the natural healing environment. Michael Will, CEO of Pegasus, said: “Receiving

Known as BLOSSOM (behavioral modification and lorcaserin second study for obesity management) and BLOOM-DM (behavioral modification and lorcaserin for overweight and obesity management in diabetes mellitus), these one-year,

Anna Gluskin, president and CEO of Generex, said: “We are excited to secure a significant purchase order in the short time since we announced our collaboration. The Middle

Guerbet submitted a marketing authorization application (MAA) to the European Medicines Agency (EMEA) in November 2006 seeking marketing approval for Sinerem for the detection and characterization of metastatic

The deal was structured as an asset purchase under which a newly formed subsidiary of Inverness acquired substantially all of the assets of Matritech for aggregate consideration of

Combining Rosetta Genomics know-how and proprietary technologies with Columbia University Medical Center’s expertise in cancer, researchers are expected to screen for microRNAs that may be used as potential

Martek manufactures nutritional oils that contain the long-chain polyunsaturated fatty acids docosahexaenoic acid (DHA) and arachidonic acid (ARA), both of which are naturally present in breast milk. Clinical

Puricase 8mg administered by a two-hour intravenous infusion every two weeks or every four weeks met the primary efficacy endpoint in the intent to treat (ITT) and per